Share on PinterestGrains such as millet, brown rice, and oats can help lower cholesterol levels. Eleonora Galli/Getty Images New research has found that ancient grains such as oats and brown …
patients
-
-
Diabetes Complications
Diabetic patients living in rural areas are more likely to develop complications, study finds
by News Sourceby News SourceGraphical abstraction. credit: diabetes care (2024). DOI: 10.2337/dc23-1552 It is well established that people living in rural areas of the United States are more likely to develop diabetes and experience …
-
Type 1
Innovative MicroGlucagon solution aims to transform insulin therapy for patients with type 1 diabetes
by News Sourceby News SourceResearchers in Trondheim are developing a new drug for diabetics who must take daily insulin injections. The key is a hormone that relaxes the smallest blood vessels inside. Norwegians lead …
-
ATLANTA — The weight loss and heart failure benefits of semaglutide (Wegovy) extend to patients with obesity-related heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes, the STEP-HFpEF …
-
Emotional Effects
The effect of social support, diabetes management self-efficacy, and diabetes distress on resilience among patients with type 2 diabetes: a moderated mediation analysis | BMC Public Health
Care D. 6. Glycemic targets: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S61–70. MathSciNet Google Scholar Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, …
-
Blood Sugar Management
Providing artificial pancreas technology to diabetic patients
by AOL Staffby AOL StaffThis technology automates the release of insulin into the bloodstream [Getty Images] Tens of thousands of people with type 1 diabetes in the UK are to be given a new …
-
Type 2
Medscape “Making the invisible visible”: CGM provides insight into T2D. Several studies of continuous blood glucose monitoring in patients with type 2 diabetes have shown improvements in clinical parameters. …3 days ago
by News Sourceby News SourceMedscape “Making the invisible visible”: CGM provides insight into T2D. Several studies of continuous blood glucose monitoring in patients with type 2 diabetes have shown improvements in clinical parameters. …3 …
-
Type 2
Willingness to pay (WTP) for new treatment options for diabetes: A study among patients at a tertiary care center.
by News Sourceby News Sourcespecialty Please chooseI’m not a medical professional.Allergy and immunologyanatomyanesthesiologyCardiac, thoracic, and vascular surgerycardiologyCritical caredentalDermatologyDiabetes and endocrinologyemergency medical careepidemiology and public healthRegular medicineForensic medicineDepartment of GastroenterologyGeneral medical treatmentgeneticsgeriatric medicinemedical policyHematologyHIV/AIDShospital-based medical …
-
Glucagon-like peptide 1 (GLP-1) receptor agonists are the latest blockbuster drugs thanks to their powerful ability to help patients lose weight. But shortages are expected to last until the end …
-
Type 2
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis | BMC Medicine
by Yu Anby Yu AnAhmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet (London, England). 2022;400(10365):1803–20. Article PubMed Google Scholar IDF diabetes Atlas. 9th edn. Brussels, Belgium: International Diabetes …